Vimarsana
Biggest News Aggregation in the World

Page 3 - David Guyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Guyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Guyer Today - Breaking & Trending Today

Vaccines tsar sells biotech start-up to US pharma group Merck in £2.4bn deal - Vimarsana News

Vaccines tsar sells biotech start-up to US pharma group Merck in £2.4bn deal

EyeBio chairman Dame Kate Bingham (pictured) led Britain's Covid vaccine task force in early 2020 and is the chairman of EyeBio.

Oswego County TodayDist. Gov. Receives Melvin Jones Fellowship Award From Fulton Lions Club - Vimarsana News

Oswego County TodayDist. Gov. Receives Melvin Jones Fellowship Award From Fulton Lions Club

FULTON - Lion Paul Forestiere, Lions District 20-Y governor, was presented with the Melvin Jones Fellowship award—the highest honor given to a Lion— at the Fulton club’s January meeting, it was announced by club President Patrick Devendorf. “The Melvin Jones Fellowship is the Lions International Foundation’s highest honor,” Devendorf said. “It represents humanitarian qualities such…

Some Knox County Schools playgrounds are getting a face lift - Vimarsana News

Some Knox County Schools playgrounds are getting a face lift

The Knox Education Foundation reports that $2.2 million has been committed for the entire project.

Source: wbir.com
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases - Vimarsana News

EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases

NEW YORK & LONDON--(BUSINESS WIRE)--Nov 14, 2023--

EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal - Vimarsana News

EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal

EyeBio doubles the size of its original Series A raise with an additional $65 million, with new investors Bain Capital Life Sciences, Omega Funds and Vertex Ventures HC joining the round to support accelerated development of its innovative retinal disease pipelineCompletes enrollment of Multiple Ascending Dose phase...